A CROSS-SECTIONAL STUDY OF PATIENTS RECEIVING TREATMENT FOR HYPERTENSION AND ITS COMPLICATIONS: PROFILING CASES IN A TERTIARY CARE HOSPITAL LOCATED IN MANDYA

Pavan G. K., Dr. Manu P. R.*, Poorva S., Sandeep S. and Dr. Arpitha T. K.

ABSTRACT

Background: Our study aims to estimate the treatment and adequate control of hypertension among the study subjects. Hypertension means elevated systemic blood pressure that often has no symptoms, resulting from the physical force exerted by the blood on the arterial walls of the heart. A blood pressure reading that shows nearly to120/80 mmHg is considered normal. It is alarming that globally, more than 1 billion adults presently have hypertension, and this number shows that it will increase to 1.5 billion in the next decade. Earlier reports indicate a rapid rise in hypertension prevalence in developing countries, making it a significant cause of death and disability. To describe the profile of patients receiving treatment for hypertension and associated complications. And also to describe the treatment pattern involved in it. Objective: To describe the stages of hypertensive patients. And to describe the medications given to hypertension patients Additionally, this is to provide information on the medication used for patients admitted to MIMS Mandya who have hypertensive complications. Methods and Methodology: A cross-sectional study consisting of 355 cases of hypertension and related complications was conducted at the Department of General Medicine, MIMS Mandya, between July 2023 and December 2023. The findings revealed that the higher number of patients comes under the age range of 60-69, with 49 (13.8%) males and 63 (17.7%) females. The majority of the complications were HTN+DM+others (87, or 24.50%). The majority of patients come under Stage 1 rather than Stage 2.A greater number of people under monotherapy were treated with CCB (i.e., amlodipine) and combination therapy was treated the majority wise 47.83% ACE+CCB+BetaBlockers. The most common HTN-associated complications were treated with aspirin, clopidogrel, and atorvastatin. Conclusion: In a total of 355 cases, Stage 1 is more than Stage 2. The majority of the patients with monotherapy were treated with CCB. Combination therapy is mostly treated with ACE, CCB, and beta blockers. HTN-associated complications patients were treated more with aspirin, Clopidogrel, and atorvastatin.

Keywords: Hypertension, complications, treatment, cross-sectional, MIMS.